Executive Director, Global Lung Marketing
Regeneron Pharmaceuticals
Summary
The Executive Director, Global Lung Marketing, is a member of the Oncology Business Unit with accountability for leading and shaping commercialization and driving performance of Oncology solid tumor products under lung cancer indications globally, including full responsibility for US strategy and performance.
Job description
Key Responsibilities
- Leads and inspires large marketing tumor focused marketing team with US and International HQ marketing team members as well as US field based team members.
- Establishes trust within the team at all levels, and with cross functional partners.
- Creates environment for learning agility, developing marketing talent and attracting leaders to the team.
- Establishes and evolves the global tumor strategy to drive differentiation and portfolio value across geographies, balancing US and International market input into global strategy build.
- Plans business effectively for global and local market execution, being agile and able to balance/prioritize overall tactical initiatives to build and implement strategy.
- Drives and leads global brand planning, able to use tumor critical thinking to develop meaningful brand and asset strategies to increase the value of the assets in these tumor areas.
- Works in close collaboration with Clinical, Medical Affairs and Field Medical to ensure strategic alignment with Medical Education strategic plans.
- Provides strategic input into Lung Marketing Team collaboration with Insights and Data Analytics teams to conduct global market analyses and translate them into clear strategic choices and prioritization globally.
- Represents the tumor area in decision-making forums to influence prioritization, resource allocation, and long-range planning based on scientific & commercial potential.
- Works closely/collaboratively with other disease area leads to ensure overall alignment and harmony for the brand.
- Manages team of direct reports and their respective teams, ensuring alignment with Global strategy and vision.
- Develops professional relationships and contacts with global physician experts and attends key congresses.
- Creates processes and drives initiatives related to commercial launch and marketing efforts, proactively addressing hurdles in oncology asset commercialization.
- Maintains line of sight to global P&L for skin cancer products across markets and accountable for US P&L.
- Ensures the development, implementation, and administration of marketing processes, programs, and internal reports are consistent with corporate guidance and all regulatory, legal, ethical guidelines.
- Supports team efforts to develop promotional content, including ensuring Medical/Legal/Regulatory Review committee effectiveness.
- Manages and develops team members, ensuring their continued development and growth.
- Ensures that team develops and tracks indicators to monitor success of promotional activities and refines strategy/tactics based on target outcomes.
- Provides consistent reporting of status, future planning, and issues/challenges to VP of Global Oncology Marketing.
- Supports VP of Global Oncology Marketing with senior leadership reporting relevant to Lung business.
- Ensures alignment with other disease area leads.
- Works cross functionally to create, manage and track US and Global budget within Lung to ensure team is operating within the approved budget and phasing and proactively identifying efficiencies.
Requirements
- Bachelor's degree at a minimum
- 15 years of progressive experience in pharmaceutical marketing, brand strategy and execution
- Oncology experience is preferred and NSCLC experience a plus
- Deep experience in global commercial, marketing, and brand positioning and strategy development for oncology projects in US
- Experience in marketing outside of US markets with an appreciation for high-level access and commercial challenges in those markets/geographic regions
- Exemplary marketing technical skills, ranging from strategy to tactical execution, extensive experience in and understanding of brand management
- Proven track record of market analysis and identifying growth opportunities on a global scale
- Understanding of global to local market trade-offs during global commercialization planning for Oncology assets
- Experience leading cross-functional teams within a pharmaceutical or healthcare organization in the US and outside of the US, specifically for oncology assets
- Track record of adapting strategies based on market access, regulatory, development, and other cross-functional considerations
- Track record of creating and driving initiatives to support global launch planning and marketing, and life cycle management strategy and planning
- Experience in leading and developing long range brand plans, budgets and forecasts within commercial teams in the pharma/biotech industry
- Strong analytical skills for ease of tracking and communicating metrics
- Ability to communicate HCP/KOL engagement levels and overall project results to management and cross-functional partners
- Strong project and process skills with attention to detail
- Ability to communicate and act promptly; demonstrated initiative, creativity, and ability to stay agile and work effectively in complex, rapidly changing environments
- Must be proactive and able to prioritize, comfortable leading in ambiguity
- Good interpersonal and presentation skills both internally & externally
- Proficient understanding of oncology provider treatment environment and economics across academic and community hospitals and clinics, buy & bill, specialty pharmacy, group purchasing organizations, IDNs, PHS hospitals, hospital and system pharmacy, and payers
- Understanding of oncology therapeutic area, drug development process, & regulatory environment
- Extensive people management experience
- Preferred prior pharmaceutical sales experience
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, dental, vision insurance
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.